Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-02-02

Clinical Trial Update: Cyclosporine Or Methotrexate for Pediatric Alopecia Areata: Routine Clinical Care Effectiveness Study [Phase 4]

View source ↗

Summary

A Phase 4 pediatric trial evaluating the effectiveness of cyclosporine or methotrexate for alopecia areata, currently recruiting in routine clinical care.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • CYCLOSPORINE (cyclosporine)
  • METHOTREXATE (METHOTREXATE)

Snippet

Sponsor: Erasmus Medical Center | Conditions: Alopecia Areata(AA), Alopecia Areata (AA) | Phase 4 | Status: RECRUITING